
Sun Jae Yoo
Examiner (ID: 5581, Phone: (571)272-9074 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1626, 1621, 1609, 1622 |
| Total Applications | 1919 |
| Issued Applications | 1171 |
| Pending Applications | 215 |
| Abandoned Applications | 564 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15556735
[patent_doc_number] => 20200062779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => THERAPEUTIC COMPOUNDS AND COMPOSITIONS, AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/668714
[patent_app_country] => US
[patent_app_date] => 2019-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29596
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16668714
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/668714 | THERAPEUTIC COMPOUNDS AND COMPOSITIONS, AND METHODS OF USE THEREOF | Oct 29, 2019 | Abandoned |
Array
(
[id] => 15831749
[patent_doc_number] => 20200131156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => ARYLSULFONYLPYROLECARBOXAMIDE DERIVATIVES AS Kv3 POTASSIUM CHANNEL ACTIVATORS
[patent_app_type] => utility
[patent_app_number] => 16/667563
[patent_app_country] => US
[patent_app_date] => 2019-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16941
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16667563
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/667563 | ARYLSULFONYLPYROLECARBOXAMIDE DERIVATIVES AS Kv3 POTASSIUM CHANNEL ACTIVATORS | Oct 28, 2019 | Abandoned |
Array
(
[id] => 15496011
[patent_doc_number] => 20200048194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-13
[patent_title] => SUBSTITUTED BENZAMIDES
[patent_app_type] => utility
[patent_app_number] => 16/653210
[patent_app_country] => US
[patent_app_date] => 2019-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29189
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 202
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16653210
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/653210 | SUBSTITUTED BENZAMIDES | Oct 14, 2019 | Abandoned |
Array
(
[id] => 18980088
[patent_doc_number] => 11905248
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-20
[patent_title] => Compounds that modulate intracellular calcium
[patent_app_type] => utility
[patent_app_number] => 16/653475
[patent_app_country] => US
[patent_app_date] => 2019-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 73742
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16653475
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/653475 | Compounds that modulate intracellular calcium | Oct 14, 2019 | Issued |
Array
(
[id] => 17421192
[patent_doc_number] => 11254633
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-22
[patent_title] => Cannabis thin layer decarboxylation
[patent_app_type] => utility
[patent_app_number] => 16/602455
[patent_app_country] => US
[patent_app_date] => 2019-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 23
[patent_no_of_words] => 16767
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16602455
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/602455 | Cannabis thin layer decarboxylation | Oct 6, 2019 | Issued |
Array
(
[id] => 15589607
[patent_doc_number] => 20200071338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => CAVITAND COMPOSITIONS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/565981
[patent_app_country] => US
[patent_app_date] => 2019-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26793
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16565981
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/565981 | Cavitand compositions and methods of use thereof | Sep 9, 2019 | Issued |
Array
(
[id] => 15324069
[patent_doc_number] => 20200002364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => WATER-SOLUBLE ACETAMINOPHEN ANALOGS
[patent_app_type] => utility
[patent_app_number] => 16/565173
[patent_app_country] => US
[patent_app_date] => 2019-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12246
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16565173
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/565173 | Water-soluble acetaminophen analogs | Sep 8, 2019 | Issued |
Array
(
[id] => 19151164
[patent_doc_number] => 11976060
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-07
[patent_title] => Method for preparing beta-lactam derivative
[patent_app_type] => utility
[patent_app_number] => 17/256088
[patent_app_country] => US
[patent_app_date] => 2019-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8517
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17256088
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/256088 | Method for preparing beta-lactam derivative | Sep 3, 2019 | Issued |
Array
(
[id] => 15324073
[patent_doc_number] => 20200002366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => CYTOTOXIC PLATINUM COMPLEX, ITS PREPARATION AND THERAPEUTIC USE
[patent_app_type] => utility
[patent_app_number] => 16/558546
[patent_app_country] => US
[patent_app_date] => 2019-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9391
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16558546
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/558546 | Cytotoxic platinum complex, its preparation and therapeutic use | Sep 2, 2019 | Issued |
Array
(
[id] => 15342549
[patent_doc_number] => 20200009166
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-09
[patent_title] => SORAFENIB OR REGORAFENIB TROXACITABINE PHOSPHORAMIDATE PRODRUG COMBINATION THERAPY FOR LIVER CANCER
[patent_app_type] => utility
[patent_app_number] => 16/557511
[patent_app_country] => US
[patent_app_date] => 2019-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9181
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16557511
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/557511 | Sorafenib or regorafenib troxacitabine phosphoramidate prodrug combination therapy for liver cancer | Aug 29, 2019 | Issued |
Array
(
[id] => 15264579
[patent_doc_number] => 20190381023
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING THE PPAR AGONIST INT-131 AND NRF2 ACTIVATORS
[patent_app_type] => utility
[patent_app_number] => 16/553219
[patent_app_country] => US
[patent_app_date] => 2019-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31602
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16553219
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/553219 | Pharmaceutical compositions comprising the PPAR agonist INT-131 and Nrf2 activators | Aug 27, 2019 | Issued |
Array
(
[id] => 15254055
[patent_doc_number] => 20190375761
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-12
[patent_title] => Inhibitors of RAD52 Recombination Protein and Methods Using Same
[patent_app_type] => utility
[patent_app_number] => 16/547184
[patent_app_country] => US
[patent_app_date] => 2019-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17824
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 329
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16547184
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/547184 | Inhibitors of RAD52 recombination protein and methods using same | Aug 20, 2019 | Issued |
Array
(
[id] => 18172665
[patent_doc_number] => 11572362
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-07
[patent_title] => Pyrrolo[1,2-b]pyridazine derivatives
[patent_app_type] => utility
[patent_app_number] => 16/539753
[patent_app_country] => US
[patent_app_date] => 2019-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32468
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 647
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16539753
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/539753 | Pyrrolo[1,2-b]pyridazine derivatives | Aug 12, 2019 | Issued |
Array
(
[id] => 15175183
[patent_doc_number] => 20190358183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-28
[patent_title] => Methods for Use in Support of Planned Supplement and Food Ingredient Products for Diagnosis and Treatment of Metabolic Syndrome
[patent_app_type] => utility
[patent_app_number] => 16/534382
[patent_app_country] => US
[patent_app_date] => 2019-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32070
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16534382
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/534382 | Methods for use in support of planned supplement and food ingredient products for diagnosis and treatment of metabolic syndrome | Aug 6, 2019 | Issued |
Array
(
[id] => 15556683
[patent_doc_number] => 20200062753
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
[patent_app_type] => utility
[patent_app_number] => 16/531624
[patent_app_country] => US
[patent_app_date] => 2019-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35385
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16531624
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/531624 | 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection | Aug 4, 2019 | Issued |
Array
(
[id] => 17376998
[patent_doc_number] => 11234987
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-01
[patent_title] => Isoxazole compounds as inhibitors of heat shock proteins
[patent_app_type] => utility
[patent_app_number] => 16/528278
[patent_app_country] => US
[patent_app_date] => 2019-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25330
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 247
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16528278
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/528278 | Isoxazole compounds as inhibitors of heat shock proteins | Jul 30, 2019 | Issued |
Array
(
[id] => 18216483
[patent_doc_number] => 11591405
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-28
[patent_title] => Cytotoxic and anti-mitotic compounds, and methods of using the same
[patent_app_type] => utility
[patent_app_number] => 16/523942
[patent_app_country] => US
[patent_app_date] => 2019-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 41849
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16523942
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/523942 | Cytotoxic and anti-mitotic compounds, and methods of using the same | Jul 25, 2019 | Issued |
Array
(
[id] => 18216483
[patent_doc_number] => 11591405
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-28
[patent_title] => Cytotoxic and anti-mitotic compounds, and methods of using the same
[patent_app_type] => utility
[patent_app_number] => 16/523942
[patent_app_country] => US
[patent_app_date] => 2019-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 41849
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16523942
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/523942 | Cytotoxic and anti-mitotic compounds, and methods of using the same | Jul 25, 2019 | Issued |
Array
(
[id] => 18869858
[patent_doc_number] => 11857638
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-02
[patent_title] => Quinone-containing conjugates
[patent_app_type] => utility
[patent_app_number] => 16/523384
[patent_app_country] => US
[patent_app_date] => 2019-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 20508
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 215
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16523384
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/523384 | Quinone-containing conjugates | Jul 25, 2019 | Issued |
Array
(
[id] => 17266374
[patent_doc_number] => 11191778
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-07
[patent_title] => Multifunctional linker technology containing an N4 group
[patent_app_type] => utility
[patent_app_number] => 16/523044
[patent_app_country] => US
[patent_app_date] => 2019-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 13
[patent_no_of_words] => 13752
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16523044
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/523044 | Multifunctional linker technology containing an N4 group | Jul 25, 2019 | Issued |